Lumír Ondrej Hanuš, Doctor of Sciences, CSc, RNDr Biography
Research Fellow in Medicinal Chemistry and Natural Products at Hebrew University
Pro to the question "Should Marijuana Be a Medical Option?"
"The great advantage of treatment with cannabis is the fact that the patient can not overdose. Cannabis is one of the safest drugs known. Experience with its application and exploration of its use as a therapy or for recreational purposes over centuries and millennia has adequately demonstrated that it is a safe drug. It is especially safe for persons of sound mental health. Moreover, the treatment of cannabis is very cheap if it is grown by the patient himself..."
"Cannibus Is One of the Safest Drugs Known, Says Israeli Professor Lumír Hanus," translated from Czech by Google Translate, zpravy.idnes.cz, June 5, 2010
Experts Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
Involvement and Affiliations:
Research Fellow, Medicinal Chemistry and Natural Products, School of Pharmacy, Hebrew University, Jerusalem, 2008-present
Doctor Honoris Causa, Palacký University of Olomouc (Czech Republic), May 2011
Outstanding Immigrant Scientist, State of Israel, Apr. 2010
Professor, Medicinal Chemistry and Natural Products, School of Pharmacy, Hebrew University, 2003-2008
Doctor Honoris Causa, Masaryk University (Czech Republic), Apr. 2007
Memorial Medal, Palacký University of Olomouc, Nov. 2006
Hanuš Medal, The Czech Chemical Society in Prague, Sep. 2005
Assistant Professor, Medicinal Chemistry and Natural Products, School of Pharmacy, Hebrew University, 2001-2003
Doctor of Sciences (the second and highest post-graduate academic degree in the Czech Republic), Pharmaceutical Chemistry, Charles University of Prague (Czech Republic), 1995
Associate Professor (distinct from the professional position; awarded by the rector after a certain number of years of teaching and after a successful thesis defense), Organic Chemistry, Palacký University of Olomouc, 1994
CSc (Candidate of Chemical Sciences, equivalent to a PhD), Analytical Chemistry, Palacký University of Olomouc (Czechoslovakia), 1984
RNDr (Doctor of Natural Sciences, awarded for elaborating a Master's thesis and colloquially referred to as a "small doctorate"), Palacký University of Olomouc, 1974
MSc (Master of Sciences), Analytical Chemistry, Palacký University of Olomouc, 1972
Phone: 972-2-675-8042 Fax: 972-2-675-8201 Email:[email protected] Website: None found
Cowritten with Saleh Abu-Lafi and Ester Fride, et al., "2-Arachidonyl Glyceryl Ether, a Novel Endogenous Agonist of the Cannabinoid CB1 Receptor," Proceedings of the National Academy of Sciences, 2001
Cowritten with Susanna Tchilibon, Tiziana Bisogno, and Luciano De Petrocellis, et al., "Molecular Targets for the Non-psychotropic Plant Cannabinoid, Cannabidiol, and Some of Its Synthetic Analogues: Effect on Vanilloid VR1 Receptors and on the Cellular Uptake and Hydrolysis of the Endocannabinoid Anandamide," British Journal of Pharmacology, 2001
Cowritten with Eli Breuer and Susanna Tchilibon, et al., "HU-308: A Specific Agonist for CB2, a Peripheral Cannabinoid Receptor," Proceedings of the National Academy of Sciences, Oct. 8, 1999
Cowritten with Raphael Mechoulam, et al., "Two New Unsaturated Fatty Acid Ethanolamides in Brain that Bind to the Cannabinoid Receptor," Journal of Medicinal Chemistry, Oct. 1993
Cowritten with William Anthony Devane, et al., "Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor," Science, Dec. 18, 1992
Dr. Hanuš isolated and first described the structure of anandamide, an endogenous cannabinoid neurotransmitter.